Cargando…
A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression
Intellectual disability (ID) is a neurological disorder arising from early neurodevelopmental defects. The underlying genetic and molecular mechanisms are complex, but are thought to involve, among others, alterations in genes implicated in axon guidance and/or neural circuit formation as demonstrat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143429/ https://www.ncbi.nlm.nih.gov/pubmed/35628442 http://dx.doi.org/10.3390/ijms23105632 |
_version_ | 1784715804095283200 |
---|---|
author | Paganoni, Alyssa J. J. Amoruso, Federica Porta Pelayo, Javier Calleja-Pérez, Beatriz Vezzoli, Valeria Duminuco, Paolo Caramello, Alessia Oleari, Roberto Fernández-Jaén, Alberto Cariboni, Anna |
author_facet | Paganoni, Alyssa J. J. Amoruso, Federica Porta Pelayo, Javier Calleja-Pérez, Beatriz Vezzoli, Valeria Duminuco, Paolo Caramello, Alessia Oleari, Roberto Fernández-Jaén, Alberto Cariboni, Anna |
author_sort | Paganoni, Alyssa J. J. |
collection | PubMed |
description | Intellectual disability (ID) is a neurological disorder arising from early neurodevelopmental defects. The underlying genetic and molecular mechanisms are complex, but are thought to involve, among others, alterations in genes implicated in axon guidance and/or neural circuit formation as demonstrated by studies on mouse models. Here, by combining exome sequencing with in silico analyses, we identified a patient affected by severe ID and cognitive regression, carrying a novel loss-of-function variant in the semaphorin 3E (SEMA3E) gene, which encodes for a key secreted cue that controls mouse brain development. By performing ad hoc in vitro and ex vivo experiments, we found that the identified variant impairs protein secretion and hampers the binding to both embryonic mouse neuronal cells and tissues. Further, we revealed SEMA3E expression during human brain development. Overall, our findings demonstrate the pathogenic impact of the identified SEMA3E variant and provide evidence that clinical neurological features of the patient might be due to a defective SEMA3E signaling in the brain. |
format | Online Article Text |
id | pubmed-9143429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91434292022-05-29 A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression Paganoni, Alyssa J. J. Amoruso, Federica Porta Pelayo, Javier Calleja-Pérez, Beatriz Vezzoli, Valeria Duminuco, Paolo Caramello, Alessia Oleari, Roberto Fernández-Jaén, Alberto Cariboni, Anna Int J Mol Sci Article Intellectual disability (ID) is a neurological disorder arising from early neurodevelopmental defects. The underlying genetic and molecular mechanisms are complex, but are thought to involve, among others, alterations in genes implicated in axon guidance and/or neural circuit formation as demonstrated by studies on mouse models. Here, by combining exome sequencing with in silico analyses, we identified a patient affected by severe ID and cognitive regression, carrying a novel loss-of-function variant in the semaphorin 3E (SEMA3E) gene, which encodes for a key secreted cue that controls mouse brain development. By performing ad hoc in vitro and ex vivo experiments, we found that the identified variant impairs protein secretion and hampers the binding to both embryonic mouse neuronal cells and tissues. Further, we revealed SEMA3E expression during human brain development. Overall, our findings demonstrate the pathogenic impact of the identified SEMA3E variant and provide evidence that clinical neurological features of the patient might be due to a defective SEMA3E signaling in the brain. MDPI 2022-05-18 /pmc/articles/PMC9143429/ /pubmed/35628442 http://dx.doi.org/10.3390/ijms23105632 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Paganoni, Alyssa J. J. Amoruso, Federica Porta Pelayo, Javier Calleja-Pérez, Beatriz Vezzoli, Valeria Duminuco, Paolo Caramello, Alessia Oleari, Roberto Fernández-Jaén, Alberto Cariboni, Anna A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression |
title | A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression |
title_full | A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression |
title_fullStr | A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression |
title_full_unstemmed | A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression |
title_short | A Novel Loss-of-Function SEMA3E Mutation in a Patient with Severe Intellectual Disability and Cognitive Regression |
title_sort | novel loss-of-function sema3e mutation in a patient with severe intellectual disability and cognitive regression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143429/ https://www.ncbi.nlm.nih.gov/pubmed/35628442 http://dx.doi.org/10.3390/ijms23105632 |
work_keys_str_mv | AT paganonialyssajj anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT amorusofederica anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT portapelayojavier anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT callejaperezbeatriz anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT vezzolivaleria anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT duminucopaolo anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT caramelloalessia anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT oleariroberto anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT fernandezjaenalberto anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT caribonianna anovellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT paganonialyssajj novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT amorusofederica novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT portapelayojavier novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT callejaperezbeatriz novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT vezzolivaleria novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT duminucopaolo novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT caramelloalessia novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT oleariroberto novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT fernandezjaenalberto novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression AT caribonianna novellossoffunctionsema3emutationinapatientwithsevereintellectualdisabilityandcognitiveregression |